We envision a world where country leaders and their partners have the tools, evidence, financial capacity, human resources, and political will to control, eliminate, and eventually eradicate malaria.
What we do
We focus on developing, introducing, and evaluating new tools and approaches; optimizing the delivery of current tools and approaches; improving data use through enhanced measurement tools, metrics, and information systems; and strengthening endemic country expertise to create sustainable systems.
We partner with ministries of health in malaria-endemic countries to support the development of resilient health systems by generating evidence to inform policy, strengthening the capacity of community health workers, and increasing coverage of proven health interventions–against malaria and other diseases.
We support health ministries in digital transformation—developing skills, systems, and governance—for timely and quality use of data technologies to improve decision-making across efforts to end malaria.
Our investments in malaria have been leveraged to effectively to prevent, detect, and respond to emerging global health threats, including integrating multiple sources of data, applying mathematical modeling, and expanding surveillance and laboratory capacities.
We work across the innovation and access pipeline—from generating new malaria tools to expanding access to current ones, through the analysis of market dynamics and policy windows.
Malaria vaccine development & introduction
Market access to existing & new tools
Research & evaluation
Surveillance & digital platforms
Routine data collection & reporting, data quality assessments, data use training & integration
Data-driven analytics & mathematical modeling
Policy formulation & operational planning
Management, leadership & capacity strengthening at all levels of the health system
Community case management & workforce training
Where we work
We have active malaria projects in more than 40 countries across 3 continents:
Africa: Angola, Benin, Burkina Faso, Cameroon, Côte d'Ivoire, The Democratic Republic of the Congo, Ethiopia, The Gambia, Ghana, Guinea, Kenya, Liberia, Madagascar, Malawi, Mali, Mozambique, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe.
Asia-Pacific: Cambodia, India, Indonesia, Japan, Lao PDR, Myanmar, Papua New Guinea, Thailand, and Vietnam.
Americas: Brazil, Colombia, Guatemala, Honduras, Panama, and Peru.
PATH Malaria Events
What’s next with malaria vaccines? Opportunities and challenges for the next 5 years
Thursday, March 23
7:00am PT | 10:00am ET | 2:00pm GMT | 4pm CAT | 9:00pm ICT
The first malaria vaccine to be recommended and prequalified by WHO is moving into broader implementation, while a leading malaria vaccine candidate is in Phase 3 evaluation. Other immunization approaches, including monoclonal antibodies and mRNA vaccines, are in development. This webinar will explore key challenges to vaccine development and access—financial, scientific, and delivery—with perspectives offered by experts in their respective fields.
The webinar will be moderated by John Bawa, Africa Team Lead, Vaccine Implementation at PATH and will feature the following speakers: Ashley Birkett, PhD, Global Head of Malaria Vaccines & Biologics at PATH, Hema Srinivasan, Chief Access Officer at MedAccess, and Jane Grant, MSc, Research Assistant at the London School of Hygiene & Tropical Medicine.
There will be a Q&A session at the end of the webinar. The webinar will be recorded and available to those who register.
Recordings from our past webinars are available here.
Global Head, Malaria Vaccines and Biologics, Center for Vaccine Innovation and Access
Scientific Director and Lead of Malaria Diagnostics
Director, Market Dynamics
Deputy Director, Malaria and Neglected Tropical Diseases
Deputy Director, Malaria Vaccines and Biologics, Center for Vaccine Innovation and Access
Program Director of Management and Administration, Malaria and Neglected Tropical Diseases
Director of Policy and External Engagement, Malaria and Neglected Tropical Diseases
Senior Scientific Advisor, Malaria and Neglected Tropical Diseases
Project Director, Malaria Emergency Operations Centers
Project Director, VectorLink
West Africa Malaria Regional Director, Malaria and Neglected Tropical Diseases
Project Director, Zambia Digital Community Health
Technical Director, PMI Insights
Project Director, PMI Insights and ATSB
Project Director, MACEPA
Chief of Party, PAMO Plus
Arantxa Roca Feltrer
Regional Malaria Director, MACEPA
Research Scientist, Malaria and Neglected Tropical Diseases
Project Director, New Nets
A two-page summary describing who we are, where we work, and what we do.
Peer-reviewed publications from PATH Malaria researchers and scientists in collaboration with external partners